BioSpace News Archive

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that Michael Amoroso, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 10:30 a.m. ET. A live and archived webcast of the presentation will be available on the investor section of the Abeona Therapeutics website at www.abeonatherapeutics.com . Abou

Pixium Vision announces business update and key upcoming milestonesto deliver on its business plan

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that it has entered into an additional agreement with Lonza to support drug substance manufacturing for its global supply chain.

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced today that its three wholly owned subsidiaries, Helomics, TumorGenesis and Soluble Biotech, will be attending BIO DIGITAL, a key international biotech partnering event held virtually on June 10-11 & 14-18, 2021.

Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the appointment of William (Bill) H. Carson, M.D., as Chairman of the Board of Directors.

Results Will Advance Understanding of Potential Predictive Responses of Markers in High-Grade Brain Cancer Patients

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced it entered a 15-year lease agreement with Hamilton, Ontario-based McMaster University to build a 27,000 square foot current Good Manufacturing Practice (GMP

Newly appointed board member brings more than two decades of experience from across the medical device and telehealth industries

Greenphire, the global leader in financial lifecycle management for clinical trials, has announced today that it has joined the Decentralized Trials & Research Alliance (DTRA), a burgeoning alliance of 100 life science and healthcare organizations that seek to accelerate the adoption of patient-focused, decentralized clinical trials and research

Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced initial results from an automation study of its CRISPR-based test for SARS-CoV-2 in partnership with NorDx Laboratories